Skip to main content
GutCited

Fructooligosaccharides (FOS) для Chronic Constipation

C Доказательства Доказательства ограничены небольшими исследованиями, однако имеются некоторые положительные сигналы.

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Итог

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None или: None Outcome: gut health outcomes including microbiota modulation and SCFA … Эффект: None None

Популяция: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None или: Placebo Outcome: Weekly spontaneous bowel movements Эффект: 4.94 vs 3.00 (P<0.001) P<0.001

Популяция: Older adults >=60 with functional constipation (Rome IV)

Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g или: None Outcome: Constipation symptoms Эффект: None P < 0.05

Популяция: Constipation patients

Randomized Controlled Trial Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g или: Placebo Outcome: Constipation symptoms Эффект: None None

Популяция: Constipation patients

Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None или: None Outcome: Constipation symptoms Эффект: OR: 10.36 p < 0.00001

Популяция: Constipation patients

Randomized Controlled Trial Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None или: Placebo Outcome: Constipation symptoms Эффект: None None

Популяция: Constipation patients

Key Statistics

4

Исследования

350

Участники

↑

Positive

C

Оценка

Referenced Papers

Journal of Parkinson's … 2024 4 цитирований
Carbohydrate polymers 2022 77 цитирований
Journal of physiology … 2009 312 цитирований
Journal of the … 2007 84 цитирований
BioFactors (Oxford, England) 2004 48 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

Верхний предел: Well-tolerated up to 20 g/day; start low to avoid excess gas

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Positive --
None 4 weeks Positive 67
2 g -- Neutral --
6 g -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Лучшее время приёма: With meals; divide doses throughout the day

Safety & Side Effects

Зарегистрированные побочные эффекты

  • ⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • ⚠ Abdominal cramping at higher doses
  • ⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
  • ⚠ Loose stools at excessive doses

Известные взаимодействия

  • ● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • ● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • ● Calcium supplements (FOS may enhance calcium absorption)

Допустимый верхний уровень потребления: Well-tolerated up to 20 g/day; start low to avoid excess gas

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Другие ингредиенты для Chronic Constipation

Fructooligosaccharides (FOS) для других состояний

References

  1. [1] Cinara Regina A V Monteiro et al.. Nutrients. 2026. Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions. doi:10.3390/nu18030372 PubMed
  2. [2] Meina Li et al.. J Nutr Health Aging. 2025. Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, … doi:10.1016/j.jnha.2025.100598 PubMed
  3. [3] Wanya Yi et al.. Food Sci Nutr. 2024. Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium. doi:10.1002/fsn3.3827 PubMed
  4. [4] Hongmin Zhen et al.. Foods. 2024. Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. doi:10.3390/foods13243993 PubMed
  5. [5] Jia Wei Hor et al.. J Parkinsons Dis. 2024. Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics. doi:10.3233/JPD-240172 PubMed
  6. [6] Kaidi Ma et al.. Anim Nutr. 2024. Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned piglets. doi:10.1016/j.aninu.2024.04.002 PubMed
  7. [7] Ashinshana U Illippangama et al.. Carbohydr Polym. 2022. Inulin as a functional ingredient and their applications in meat products. doi:10.1016/j.carbpol.2021.118706 PubMed
  8. [8] Qi Zhang et al.. Front Nutr. 2022. In vitro Study of Bifidobacterium lactis BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota. doi:10.3389/fnut.2022.890316 PubMed
  9. [9] Jan de Vries et al.. Nutrients. 2019. Effects of β-Fructans Fiber on Bowel Function: A Systematic Review and Meta-Analysis. doi:10.3390/nu11010091 PubMed
  10. [10] Daniela da Silva Souza et al.. Nutrients. 2018. Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation. doi:10.3390/nu10111602 PubMed
  11. [11] Johnson W McRorie et al.. J Acad Nutr Diet. 2017. Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and … doi:10.1016/j.jand.2016.09.021 PubMed
  12. [12] F Azpiroz et al.. Neurogastroenterol Motil. 2017. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … doi:10.1111/nmo.12911 PubMed
  13. [13] Shinji Jinno et al.. Nutrients. 2017. Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month. doi:10.3390/nu9030196 PubMed
  14. [14] Annelisa Silva E Alves de Carvalho Santos et al.. Clin Nutr. 2017. Effectiveness of nutritional treatment and synbiotic use on gastrointestinal symptoms reduction in HIV-infected patients: Randomized clinical trial. doi:10.1016/j.clnu.2016.06.005 PubMed
  15. [15] Kulwara Meksawan et al.. Perit Dial Int. 2016. Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients. doi:10.3747/pdi.2014.00015 PubMed
  16. [16] Petra A M J Scholtens et al.. World J Gastroenterol. 2014. Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review. doi:10.3748/wjg.v20.i37.13446 PubMed
  17. [17] Dan L Waitzberg et al.. Clin Nutr. 2013. Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response. doi:10.1016/j.clnu.2012.08.010 PubMed
  18. [18] Chi-Hua Yen et al.. Nutrition. 2011. Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial. doi:10.1016/j.nut.2010.02.009 PubMed
  19. [19] Esther Nova et al.. J Med Food. 2011. Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. doi:10.1089/jmf.2008.0328 PubMed
  20. [20] M Sabater-Molina et al.. J Physiol Biochem. 2009. Dietary fructooligosaccharides and potential benefits on health. doi:10.1007/BF03180584 PubMed
  21. [21] Syed H Tariq. J Am Med Dir Assoc. 2007. Constipation in long-term care. doi:10.1016/j.jamda.2007.02.009 PubMed
  22. [22] Takahisa Tokunaga. Biofactors. 2004. Novel physiological function of fructooligosaccharides. doi:10.1002/biof.552210117 PubMed
  23. [23] Nancy Moore et al.. Br J Nutr. 2003. Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. doi:10.1079/bjn2003950 PubMed
  24. [24] D B Cockram et al.. J Ren Nutr. 1998. Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. doi:10.1016/s1051-2276(98)90034-6 PubMed

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.